This submission is in response to CAI 0-503 Comprehensive Partnerships to Reduce Cancer Health Disparities. This application, submitted by the Dana-Farber/Harvard Cancer Center and its partner UMASS Boston, describes plans to transition the successful U56 Partnership to a U54: From Its Inception, the Partnership has been based on strong Institutional support, significant personal commitment of the leadership, and a belief in the institutional benefit that would be derived from a successful partnership. Two key tenets underlie the formation of our Partnership: a) a common and Intense Interest In addressing the problem of racial, ethnic, and socioeconomic disparities in cancer;and b) a belief that through the partnership, each partner will achieve benefits that neither could achieve on Its own. Through careful planning, a mature, solid, and committed partnership has evolved which has been transformative for both Institutions. This application provides extensive evidence of the ways these tenets have been operationalized and the resulting benefits, which have been substantial for both institutional partners. In addition to robust Administrative and Planning &Evaluation Cores, and two shared resources (Training Core and Statistical and Survey Methods Core), the application includes rigorous and innovative science, representing basic, clinical, and population science, as well as an innovative post-doctoral training program In nursing and health disparities. The Partnership has strong and enthusiastic personal and Institutional support from the leaders of the respective institutions. The Partnership has well-established communication, leadership, and evaluation in place, and Is guided by an outstanding, external Program Steering Committee. This Partnership is fully prepared to move to the U54 mechanism.
This strong and stable Partnership has an excellent track record of developing cancer-focused research activities at the Minority Serving Institution, strengthening the cancer disparities and outreach research programs at the Comprehensive Cancer Center, and conducting robust student training programs. The Partnership Is well-positioned to transition to a U54.
|Balboni, Michael J; Sullivan, Adam; Smith, Patrick T et al. (2018) The Views of Clergy Regarding Ethical Controversies in Care at the End of Life. J Pain Symptom Manage 55:65-74.e9|
|Koss, Sarah E; Weissman, Ross; Chow, Vinca et al. (2018) Training Community Clergy in Serious Illness: Balancing Faith and Medicine. J Relig Health :|
|Ramanadhan, Shoba; Minsky, Sara; Martinez-Dominguez, Vilma et al. (2017) Building practitioner networks to support dissemination and implementation of evidence-based programs in community settings. Transl Behav Med 7:532-541|
|Balboni, Michael J; Sullivan, Adam; Enzinger, Andrea C et al. (2017) U.S. Clergy Religious Values and Relationships to End-of-Life Discussions and Care. J Pain Symptom Manage 53:999-1009|
|Leyva, Bryan; Allen, Jennifer D; Ospino, Hosffman et al. (2017) Enhancing capacity among faith-based organizations to implement evidence-based cancer control programs: a community-engaged approach. Transl Behav Med 7:517-528|
|Park, Elyse R; Mutchler, Jan E; Perez, Giselle et al. (2017) Coping and resiliency enhancement program (CARE): a pilot study for interpreters in cancer care. Psychooncology 26:1181-1190|
|Allen, Jennifer D; Torres, Maria Idalí; Tom, Laura S et al. (2016) Dissemination of evidence-based cancer control interventions among Catholic faith-based organizations: results from the CRUZA randomized trial. Implement Sci 11:74|
|LeBaron, Virginia T; Smith, Patrick T; Quiñones, Rebecca et al. (2016) How Community Clergy Provide Spiritual Care: Toward a Conceptual Framework for Clergy End-of-Life Education. J Pain Symptom Manage 51:673-81|
|Trevino, Kelly M; Zhang, Baohui; Shen, Megan J et al. (2016) Accuracy of advanced cancer patients' life expectancy estimates: The role of race and source of life expectancy information. Cancer 122:1905-12|
|Abel, Gregory A; Albelda, Randy; Khera, Nandita et al. (2016) Financial Hardship and Patient-Reported Outcomes after Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant 22:1504-1510|
Showing the most recent 10 out of 73 publications